CCFM
VRNA

Clear Creek Financial Management’s Verona Pharma VRNA Stock Holding History

Clear Creek Financial Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-37,500
Closed -$175K – 259
2020
Q2 		$175K Hold
37,500
– – 0.05% 229
2020
Q1 		$170K Buy
+37,500
New +$206K 0.06% 155

Other funds holding VRNA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Clear Creek Financial Management's VRNA Position: Q3 2020 in Review

Clear Creek Financial Management sold out of Verona Pharma (VRNA) in Q3 2020, closing a stake of 37,500 shares — an estimated $175K sold.

Clear Creek Financial Management first reported a position in VRNA in Q1 2020 and held it in 2 quarters. The position peaked at $175K in Q2 2020. 28 funds tracked by Wall St. Rank hold VRNA as of Q3 2020.

  • Clear Creek Financial Management reported no remaining Verona Pharma position as of Q3 2020 after selling out during the quarter.
  • Clear Creek Financial Management sold 37,500 Verona Pharma shares in Q3 2020, an estimated $175K.
  • Clear Creek Financial Management first reported a position in Verona Pharma in Q1 2020 and held it in 2 quarters.
  • Clear Creek Financial Management's Verona Pharma position peaked at $175K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2020.

Based on Clear Creek Financial Management's 13F filing for Q3 2020, filed 10 Nov 2020.